Protium kleinii
Protium kleinii · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Protium kleinii is a botanical species of significant interest in the field of pharmacological research. Recent studies have focused on its potential antiinflammatory activities, highlighting its therapeutic value. Scientific investigations have specifically identified the presence of the chemical compound alpha-Amyrin within the plant. Researchers often utilize an ether extract to isolate these bioactive components for further testing. Understanding these properties provides essential insights into the plant's medicinal capabilities.
- Synonyms
- Protium Dusenii
- Common names
- Not available
- Family
- Burseraceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Protium kleinii is a fascinating botanical species recognized by several distinct regional names. It is widely known by the common name Almecega, though it is also frequently referred to as Almecega-branca. Depending on the local dialect or area, one might also encounter the name Arméssica used to describe this plant. Furthermore, the species holds significant cultural identity through names such as Guapoicí-una. It is also commonly documented under the spelling Guapoí-una, reflecting the linguistic diversity surrounding its classification.
Sources: Catalogue of Life (COL)
Synonyms
Protium kleinii is a botanical species that is frequently identified in scientific literature under an alternative name. In many taxonomic records, this plant is listed as a synonym of Protium dusenii. This nomenclature overlap occurs because different researchers have historically applied different labels to the same organism. Understanding these relational links is essential for botanists working to maintain accurate classification systems. Consequently, recognizing both names ensures that researchers are studying the same biological entity.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Protium kleinii is a fascinating member of the kingdom Plantae that showcases the intricate diversity of the natural world. This specific species is classified under the class Equisetopsida and belongs to the order Sapindales. Within this taxonomic hierarchy, it is further nested in the family Burseraceae. It also holds its place within the genus Protium, distinguishing it from other related plants. Understanding these biological relationships provides essential insight into the evolutionary history of this organism.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Sapindales |
| Family | Burseraceae |
| Genus | Protium |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Protium kleinii is a notable plant species primarily found within the diverse ecosystems of Southern America. Its geographic presence is most concentrated in Brazil, where it thrives in various ecological niches. Specifically, the species maintains a significant distribution throughout the southeastern regions of the country. This widespread availability across Brazil South and Southeast underscores its importance to the local flora. Understanding these specific habitats is essential for studying the plant's natural growth patterns and ecological role.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Protium kleinii is a self-supporting tree that serves as a sturdy component of its natural ecosystem. This species maintains a robust growth form, reaching a maximum height of 20 meters. Its impressive stature allows it to stand prominently within the forest canopy.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Protium kleinii is a native Brazilian medicinal plant that has demonstrated significant anti-inflammatory potential in recent studies. Research indicates that the ether extract of this species, along with its main active constituent alpha-amyrin, effectively inhibits ear oedema and the influx of polymorphonuclear cells. These topical applications showed a dose-related response that closely mirrors the efficacy of the steroidal drug dexamethasone. Furthermore, the extract successfully prevents the increase of proinflammatory cytokine levels, such as interleukin-1beta, during inflammatory responses. Consequently, these findings suggest that the active components of P. kleinii are promising candidates for the development of new skin-permeable anti-inflammatory drugs.
Compounds
Protium kleinii is a native Brazilian medicinal plant known for its potential to treat various inflammatory states. Research indicates that this plant contains the pentacyclic triterpene alpha-amyrin, which serves as a primary active constituent. When applied topically, both the ether extract of the plant and alpha-amyrin demonstrate a dose-related inhibition of ear oedema and neutrophil influx. Furthermore, these substances effectively prevent the increase of the proinflammatory cytokine interleukin-1beta in response to chemical triggers. Because of these potent properties, the relationship between Protium kleinii and alpha-amyrin makes them excellent candidates for developing new skin-permeable anti-inflammatory drugs.
Conditions
Protium kleinii exhibits significant medicinal properties by effectively treating various inflammatory states. Its ether extract and active constituent, alpha-amyrin, demonstrate a dose-related inhibition of ear oedema in mouse models. Furthermore, the plant helps treat inflammatory responses by reducing the influx of polymorphonuclear cells. Research also shows that its application successfully manages inflammation by preventing the increase of proinflammatory cytokine interleukin-1beta levels. These combined actions suggest that the plant is a highly capable candidate for developing skin-permeable anti-inflammatory drugs.
Preparations
Protium kleinii is prepared as an ether extract to investigate its topical anti-inflammatory properties. This specific extract contains active constituents like the pentacyclic triterpene alpha-amyrin which contribute to its medicinal effects. Research demonstrates that the ether extract provides dose-related inhibition of ear oedema and polymorphonuclear cell influx. Furthermore, applying this extract can dose-dependently prevent the increase of proinflammatory cytokine interleukin-1beta levels. These findings suggest that the ether extract of P. kleinii is a promising candidate for developing skin-permeable anti-inflammatory drugs.